Guillain-Barré syndrome, the IL-33/ST2 axis, and vitamin D
- PMID: 35514132
- DOI: 10.1111/ene.15379
Guillain-Barré syndrome, the IL-33/ST2 axis, and vitamin D
Comment in
-
Modulatory effects of vitamin D on IL -33/ ST2 immune axis in Guillain-Barré syndrome…quo vadis?Eur J Neurol. 2022 Jul;29(7):e22-e23. doi: 10.1111/ene.15389. Epub 2022 May 19. Eur J Neurol. 2022. PMID: 35524469 No abstract available.
Comment on
-
Role of altered IL-33/ST2 immune axis in the immunobiology of Guillain-Barré syndrome.Eur J Neurol. 2022 Jul;29(7):2074-2083. doi: 10.1111/ene.15334. Epub 2022 Apr 12. Eur J Neurol. 2022. PMID: 35322935
References
REFERENCES
-
- Sharma PP, Seshagiri DV, Nagappa M, et al. Role of altered IL-33/ST2 immune axis in the immunobiology of Guillain-Barré syndrome. Eur J Neurol. 2022;29(7):2074-2083. doi:10.1111/ene.15334
-
- Debnath M, Nagappa M, Dutta D, et al. Evidence of altered Th17 pathway signatures in the cerebrospinal fluid of patients with Guillain Barré Syndrome. J Clin Neurosci. 2020;75:176-180. doi:10.1016/j.jocn.2020.03.010
-
- Martens PJ, Gysemans C, Verstuyf A, Mathieu AC. Vitamin D's effect on immune function. Nutrients. 2020;12(5):1248. doi:10.3390/nu12051248
-
- De Martinis M, Ginaldi L, Sirufo MM, et al. IL-33/Vitamin D crosstalk in psoriasis-associated osteoporosis. Front Immunol. 2020. doi:10.3389/fimmu.2020.604055
-
- Sirufo MM, Ginaldi L, De Martinis M. The IL-33/ST2 axis and vitamin D as a possible emerging therapeutic target in osteoarthritis. Rheumatology (Oxford). 2021;60(8):e300. doi:10.1093/rheumatology/keab292
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical